U.S. pharma giant copyright scrapped two experimental weight loss products past yr—a the moment-every day capsule, lotiglipron, on account of elevated liver enzymes along with a two times-day by day capsule, danuglipron, as a consequence of powerful Unwanted effects—but CEO Albert Bo